Zoetis Welcomes Officials to Celebrate New R&D Building in Durham, NC, USA

Zoetis marked the official opening of its new building dedicated to diagnostics and biodevices research and development (R&D) with a ribbon cutting ceremony at its site in Durham, North Carolina. The expanded site serves as the hub for Zoetis’ engineering and diagnostics work including performance and reliability testing, as well as supporting assay development and biosciences. The new building features more than 78,000 square feet including 23,000 square feet of total lab space allotted for a biodevice engineering lab, biodevice science lab, diagnostics engineering lab and diagnostics engineering lab space.  

Attendees included North Carolina Secretary of Commerce Machelle Baker Sanders, North Carolina Representative Zack Hawkins and key company leaders including Zoetis CEO Kristin Peck, and President of Research and Development Rob Polzer. 

“We are thrilled to celebrate our new building in Durham, where our research and development team dedicated to diagnostics and engineering is based. As the innovation leader in animal health, it’s important to us to be part of the dynamic technology community here in Durham,” said Rob Polzer, Executive Vice President and President of Research and Development at Zoetis. “I am optimistic about our ability to continue to innovate in diagnostics and biodevices to meet the needs of our customers and the pets and livestock they care for.” 

Zoetis employs approximately 200 people at its site in Durham, more than half of whom are dedicated to the company’s R&D work. Other colleagues on site are dedicated to U.S. Poultry, Global BioDevices commercial operations, as well as related manufacturing and enabling functions. Since 2020, Zoetis has added more than 50 R&D jobs at its site in Durham.